Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

1 terminated/withdrawn out of 20 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
8(88.9%)
Phase 3
1(11.1%)
9Total
N/A(8)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07532369Not Yet Recruiting

Occlutech AFR Fontan Study

Role: lead

NCT07519876Recruiting

Pulmonary Embolism and Right-to-Left Shunts

Role: collaborator

NCT05387954Phase 3Recruiting

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Role: collaborator

NCT05069558Not ApplicableActive Not Recruiting

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Role: lead

NCT07421557Unknown

Expanded Access of Occlutech's Atrial Flow Regulator

Role: lead

NCT05329350Recruiting

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

Role: lead

NCT04405583Recruiting

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

Role: lead

NCT05264753Recruiting

Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Role: lead

NCT04034498Active Not Recruiting

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Role: lead

NCT05174442Recruiting

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

Role: lead

NCT07037446Enrolling By Invitation

A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Paravalvular Leaks

Role: lead

NCT03022851Not ApplicableCompleted

The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

Role: lead

NCT05136820Not ApplicableActive Not Recruiting

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Role: lead

NCT04029233Terminated

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

Role: lead

NCT01479218Not ApplicableCompleted

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Role: lead

NCT03030274Not ApplicableCompleted

The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

Role: lead

NCT03003481Completed

Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device

Role: lead

NCT04488120Not ApplicableCompleted

Occlutech Septal Occluder (Figulla Flex II) Study

Role: lead

NCT02105584Not ApplicableCompleted

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

Role: lead

NCT01153074Not ApplicableCompleted

Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

Role: collaborator

All 20 trials loaded